VXA-A1.1 Clinical Advances and Market Forecast to 2032: Drug Developments, Regulatory Milestones, Emerging Competition and Future Prospects
30 janv. 2024 06h47 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "VXA-A1.1 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The report covers the drug’s...
Overview of SAb Biotherapeutics' Drug SAB-176: Phase IIb Trial Insights, SWOT Analysis, and Market Forecast to 2032
30 janv. 2024 05h31 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "SAB-176 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers a...
In-Depth TTHX 1114 Drug Insight and Market Report 2023-2032: A Beacon of Hope for Fuchs Endothelial Corneal Dystrophy (FECD) Patients
30 janv. 2024 05h19 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "TTHX 1114 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report discusses TTHX...
Analysis of DNAtrix's Drug DNX-2401, 2023 to 2032: A Promising Candidate for Glioblastoma Multiforme (GBM) Treatment
30 janv. 2024 05h01 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "DNX-2401 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The pharmaceutical industry...
Global ADME Toxicology Testing Market to Reach $14.05 Billion by 2027—A New Research Report Unveils Future Industry Trends
29 janv. 2024 19h02 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "ADME Toxicology Testing Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global ADME toxicology testing...
Toxicology Drug Screening Market Poised for Expansion with a Surge to USD 20.31 Billion by 2028
29 janv. 2024 18h07 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Toxicology Drug Screening Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ...
TC-210 Drug and Market Report 2023-2032: Revolutionizing the Malignant Pleural Mesothelioma (MPM) Treatment Landscape
29 janv. 2024 13h09 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "TC-210 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The clinical landscape of...
Groundbreaking VE303 Therapeutic Candidate for Clostridium Difficile Infection (CDI) Sparks Transformation in Pharma Landscape: Detailed Analysis Reveals Potential Market Impact Though 2032
29 janv. 2024 12h57 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "VE303 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Cutting-Edge VE303 Drug Expected...
Market Overview of Centrexion Therapeutics' CNTX-4975 Drug, 2023-2032, Potentially Revolutionizing the Treatment Landscape for Osteoarthritis
29 janv. 2024 12h41 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "CNTX-4975 Emerging Drug Insight and Market Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. Emerging therapeutic...
Overview of Sorrento Therapeutics' RTX (MCP-101, resiniferatoxin) Drug Across the 7MM, 2023-2032
29 janv. 2024 12h37 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "RTX Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This reports delivers an...